Scinopharm TaiwanTPE:1789 -2.40%76 OCF Yield % is 3.77 as of Jul. 02, 2026, which is 0% above its 10-year median of 3.76. GuruFocus rates TPE:1789 with a GF Score™ of 76/100 and a GF Value™ of NT$27.12 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Scinopharm Taiwan ranks better than 52.14% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Scinopharm Taiwan OCF Yield % Related Terms
Scinopharm Taiwan OCF Yield % Historical Data
* Premium members only.
The historical data trend for Scinopharm Taiwan's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Scinopharm Taiwan's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scinopharm Taiwan OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Scinopharm Taiwan's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Scinopharm Taiwan's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scinopharm Taiwan (TPE:1789) has a OCF Yield % of 3.77 as of Jul. 02, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Scinopharm Taiwan and its competitors. This is near median its historical median of 3.76. Over the past decade, Scinopharm Taiwan's OCF Yield % has ranged from 1.05 to 7.26. According to the industry distribution chart, Scinopharm Taiwan ranks #482 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 47.9%.
Is Scinopharm Taiwan's OCF Yield % too high?
Scinopharm Taiwan's current OCF Yield % of 3.77 is near median its 10-year median of 3.76. Over the past 10 years, this metric has ranged from a low of 1.05 to a high of 7.26. The Drug Manufacturers industry median OCF Yield % is 3.45. Scinopharm Taiwan's value of 3.77 is 9.3% above this industry median. Based on the distribution chart, Scinopharm Taiwan ranks #482 out of 1007 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Scinopharm Taiwan has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Scinopharm Taiwan's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Scinopharm Taiwan ranks #482 out of 1007 companies for OCF Yield %. This puts Scinopharm Taiwan in the upper half of its industry. The industry median OCF Yield % is 3.45. Scinopharm Taiwan's value of 3.77 is 9.3% above this benchmark. Historically, Scinopharm Taiwan's own OCF Yield % has ranged from 1.05 to 7.26 over the past decade. While the company's 10-year median is 3.76 vs. the industry median of 3.45, Scinopharm Taiwan has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.45, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scinopharm Taiwan's current OCF Yield % of 3.77 is 9.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Scinopharm Taiwan and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scinopharm Taiwan's current OCF Yield % is 3.77, which is near median its own 10-year median of 3.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scinopharm Taiwan stock overvalued right now?
Based on GuruFocus' analysis, Scinopharm Taiwan (TPE:1789) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$27.12, compared to a current price of NT$20.30 — trading 25.1% below its estimated fair value. The current OCF Yield % is 3.77, which is near median its 10-year median of 3.76 and 9.3% above the Drug Manufacturers industry median of 3.45. Scinopharm Taiwan's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Scinopharm Taiwan (TPE:1789), the current OCF Yield % is 3.77 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scinopharm Taiwan (TPE:1789) Overvalued in 2026?
Based on GuruFocus' analysis, Scinopharm Taiwan stock appears to be undervalued.
The current stock price of NT$20.30 is trading 25.1% below its estimated GF Value™ of NT$27.12.
GuruFocus considers Scinopharm Taiwan to be Modestly Undervalued.
Key valuation signals for TPE:1789:
OCF Yield %: 3.77 (near median its 10-year median of 3.76)
GF Value™: NT$27.12 vs. price of NT$20.30 (25.1% below fair value)
Industry Position: 9.3% above the Drug Manufacturers median (#482 of 1007)
No single metric tells the full story. See the TPE:1789 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scinopharm Taiwan Ltd is mainly engaged in the manufacture of western medicines and other chemical materials, biological technology services, intellectual property rights, international trade, and the research, development, production, manufacture, and sales of Active Pharmaceutical Ingredients (API), albumin medicines, oligonucleotide medicines, peptide medicines, injections, and new small molecule drugs. The Company also provides related consulting and technical services and international trade for the above products. In addition, the Company sells chemical material reprocessed from material recycled from the Company's manufacturing process.
76GF Score
Get the complete analysis for TPE:1789
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1789 has been successfully added to your 
